These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2995511)

  • 1. Determination of immunity to varicella-zoster virus by means of an intradermal skin test.
    LaRussa P; Steinberg SP; Seeman MD; Gershon AA
    J Infect Dis; 1985 Nov; 152(5):869-75. PubMed ID: 2995511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed hypersensitivity skin test to detect susceptibility to varicella and zoster.
    Berger R; Luescher D; Just M; D'Hondt E; Bogaert H
    Postgrad Med J; 1985; 61 Suppl 4():137-41. PubMed ID: 3014471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to varicella virus of certain adults in the southeastern United States.
    Hyams PJ; Vernon S; Eckert D
    Am J Infect Control; 1984 Feb; 12(1):6-9. PubMed ID: 6322621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic evidence of reinfection with varicella-zoster virus.
    Arvin AM; Koropchak CM; Wittek AE
    J Infect Dis; 1983 Aug; 148(2):200-5. PubMed ID: 6310001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of anticomplement immunofluorescence and fluorescent antibody-to-membrane antigen tests for determination of immunity status to varicella-zoster virus and for serodifferentiation of varicella-zoster and herpes simplex virus infections.
    Gallo D; Schmidt NJ
    J Clin Microbiol; 1981 Nov; 14(5):539-43. PubMed ID: 6273453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunity to varicella-zoster virus in a normal adult population.
    Ndumbe PM; Macqueen S; Holzel H; Levinsky RJ
    J Med Microbiol; 1985 Aug; 20(1):105-11. PubMed ID: 2991523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of varicella skin test antigen over purified varicella-zoster virus glycoproteins in monitoring booster response to Oka varicella vaccine.
    Sato H; Yamamura Ji; Kageyama S; Kurokawa M; Shiraki K
    Vaccine; 2003 Dec; 22(1):15-20. PubMed ID: 14604566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Varicella zoster in hospital personnel: skin test reactivity to monitor susceptibility.
    Steele RW; Coleman MA; Fiser M; Bradsher RW
    Pediatrics; 1982 Oct; 70(4):604-8. PubMed ID: 6289236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biologic and immunologic characterization of the soluble skin-test antigen of varicella-zoster virus.
    Shiraki K; Yamanishi K; Takahashi M
    J Infect Dis; 1984 Apr; 149(4):501-4. PubMed ID: 6327833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme-linked immunosorbent assay for susceptibility to varicella.
    Shehab Z; Brunell PA
    J Infect Dis; 1983 Sep; 148(3):472-6. PubMed ID: 6311911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response determined with antibody-dependent cell-mediated cytotoxicity (ADCC), neutralizing antibody, and varicella skin test in children with natural varicella and after varicella immunization.
    Ihara T; Kato T; Torigoe S; Oitani K; Isaji M; Ito M; Kamiya H; Sakura M
    Acta Paediatr Jpn; 1991 Feb; 33(1):43-9. PubMed ID: 1649540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of varicella-zoster virus (VZV) fluorescent-antibody-to-membrane-antigen (FAMA) testing on sensitivity of determining VZV immunity in healthcare workers and on furlough days.
    Rolando L; Schneider WJ; Steinberg S; Low S; Stiles J; Gomez L; Gershon AA; Brown AE
    Infect Control Hosp Epidemiol; 2010 Sep; 31(9):972-4. PubMed ID: 20666603
    [No Abstract]   [Full Text] [Related]  

  • 14. Varicella zoster antibody testing in the care of pregnant women exposed to varicella.
    McGregor JA; Mark S; Crawford GP; Levin MJ
    Am J Obstet Gynecol; 1987 Aug; 157(2):281-4. PubMed ID: 3039845
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
    Brunell PA; Novelli VM; Keller PM; Ellis RW
    J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed-type hypersensitivity and in vitro lymphocyte response in guinea pigs immunized with a live varicella vaccine.
    Shiraki K; Yamanishi K; Takahashi M; Dohi Y
    Biken J; 1984 Mar; 27(1):19-22. PubMed ID: 6091616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Seroepidemiologic survey of varicella: Value of specific fluorescent antibody test.
    Gershon AA; Krugman S
    Pediatrics; 1975 Dec; 56(6):1005-8. PubMed ID: 172853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A simplified immunofluorescence technique for antibody to varicella-zoster membrane antigen (FAMA).
    Baba K; Yoshida M; Tawa A; Yabuuchi H; Maeda K; Takahashi M
    Biken J; 1984 Mar; 27(1):23-9. PubMed ID: 6091617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility to varicella-zoster virus in Thai children and young adults.
    Kositanont U; Wasi C; Oonsombat P; Suvatte V; Thongcharoen P
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):414-20. PubMed ID: 3006266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.